Loading...
Chemical structure of BMS-1001

GC25160

BMS-1001

Also known as (2R)-2-[[2-[(3-cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]-5-methylphenyl]methylamino]-3-hydroxypropanoic acid

BMS-1001 is a potent inhibitor of PD-1/PD-L1 interaction with EC50 of 253 nM· BMS-1001 alleviates the inhibitory effect of the soluble PD-L1 on the T-cell receptor-mediated activation of T-lymphocytes

ChemicalCAS2113650-03-4MW594.65FormulaC35H34N2O7
CAS number
2113650-03-4
Molecular weight
594.65
Formula
C35H34N2O7
Solubility
DMSO: 50 mg/mL (84·08 mM);Water: Insoluble;Ethanol: Insoluble
InChIKey
UWNXGZKSIKQKAH-SSEXGKCCSA-N
Catalogue number
GC25160
Brand
GLPBIO
Computed properties PubChem CID 131839624 · XLogP 2.7 · TPSA 130 Ų · H-bond donors 3
XLogP
2.7
TPSA
130 Ų
H-bond donors
3
H-bond acceptors
9
Rotatable bonds
12
Heavy atoms
44

SMILES CC1=CC(=C(C=C1OCC2=C(C(=CC=C2)C3=CC4=C(C=C3)OCCO4)C)OCC5=CC(=CC=C5)C#N)CN[C@H](CO)C(=O)O

Computed descriptors from PubChem (CID 131839624), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.